Clinical stage company Evaxion Biotech is using artificial intelligence (AI) to simulate the immune system and create predictive models to identify novel targets for vaccines against bacterial and ...

Axon Enterprise is rated Buy with a $515 price target, offering 33% upside as fundamentals diverge from depressed SaaS ...

If we focus on capital expenditure, our ZAR 69 million of capital expenditure shows a disciplined commitment to capital deployment with expansion in Reunert Connect infrastructure having been our ...